tm logo
TEVA PACKAGE DESIGN E
REGISTERED

on 09 Sep 2024

Last Applicant/ Owned by

TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 Dvora HaNevi'a6944020 Tel Aviv-Jaffa

IL

Serial Number

1980473 filed on 14th Aug 2019

Registration Number

TMA1254466 registered on 09th Sep 2024

Registration expiry Date

09th Sep 2034

Correspondent Address

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

TEVA PACKAGE DESIGN E

Vienna Information


5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

25 . 5 . 25

Other backgrounds divided into two or fourAutres fonds partagés en deux ou en quatre

26 . 1 . 1

CirclesCercles

26 . 1 . 5

More than two circles or ellipses, inside one another, spiralsPlus de deux cercles ou ellipses, les uns dans les autres, spirales

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 15

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses containing representations of animals, parts of animals¿ bodies or plantsSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses contenant la représentation d¿animaux, de parties du corps d¿un animal ou de végétaux

26 . 2 . 18

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses containing one or more lettersSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses contenant une ou plusieurs lettres

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 10

Quadrilaterals containing one or more circles, ellipses or polygonsQuadrilatères contenant un ou plusieurs cercles, ellipses ou polygones

26 . 4 . 12

Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 15 . 1

SpheresSphères

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 11

Letters or numerals representing a plantLettres ou chiffres représentant un végétal

Trademark usage description

pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of d Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.


Classification kind code

11

Mark Details


Serial Number

1980473

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 19th Jun 2024
Advertised
Submitted for opposition 27
on 27th May 2024
Approval Notice Sent
Submitted for opposition 26
on 27th May 2024
Approved
Submitted for opposition 22
on 10th May 2024
Search Recorded
Submitted for opposition 20
on 10th May 2024
Examiner's First Report
Submitted for opposition 287
on 12th Apr 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 28th Feb 2022
Amendment to Application
Submitted for opposition 31
on 19th Aug 2019
Formalized
Submitted for opposition 1
on 15th Aug 2019
Created
Submitted for opposition 30
on 14th Aug 2019
Filed